Found: 11
Select item for more details and to access through your institution.
Application of a Two-Analyte Integrated Population Pharmacokinetic Model to Evaluate the Impact of Intrinsic and Extrinsic Factors on the Pharmacokinetics of Polatuzumab Vedotin in Patients with Non-Hodgkin Lymphoma.
- Published in:
- Pharmaceutical Research, 2020, v. 37, n. 12, p. 1, doi. 10.1007/s11095-020-02933-6
- By:
- Publication type:
- Article
Population pharmacokinetics and exposure-response of trastuzumab emtansine in advanced breast cancer previously treated with ≥2 HER2-targeted regimens.
- Published in:
- British Journal of Clinical Pharmacology, 2017, v. 83, n. 12, p. 2767, doi. 10.1111/bcp.13381
- By:
- Publication type:
- Article
Lesson of emotions in the family: The role of emotional intelligence in the relation between filial piety and life satisfaction among Taiwanese college students.
- Published in:
- Asian Journal of Social Psychology, 2018, v. 21, n. 1/2, p. 74, doi. 10.1111/ajsp.12207
- By:
- Publication type:
- Article
Asian race and origin have no clinically meaningful effects on polatuzumab vedotin pharmacokinetics in patients with relapsed/refractory B-cell non-Hodgkin lymphoma.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2020, v. 86, n. 3, p. 347, doi. 10.1007/s00280-020-04119-8
- By:
- Publication type:
- Article
Pharmacokinetics of trastuzumab emtansine (T-DM1) as a single agent or in combination with pertuzumab in HER2-positive breast cancer patients with recurrent or locally advanced metastatic breast cancer.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Applying interpretable machine learning workflow to evaluate exposure–response relationships for large‐molecule oncology drugs.
- Published in:
- CPT: Pharmacometrics & Systems Pharmacology, 2022, v. 11, n. 12, p. 1614, doi. 10.1002/psp4.12871
- By:
- Publication type:
- Article
Physiologically‐Based Pharmacokinetic Model‐Informed Drug Development for Fenebrutinib: Understanding Complex Drug‐Drug Interactions.
- Published in:
- CPT: Pharmacometrics & Systems Pharmacology, 2020, v. 9, n. 6, p. 332, doi. 10.1002/psp4.12515
- By:
- Publication type:
- Article
Integrated Two‐Analyte Population Pharmacokinetic Model of Polatuzumab Vedotin in Patients With Non‐Hodgkin Lymphoma.
- Published in:
- CPT: Pharmacometrics & Systems Pharmacology, 2020, v. 9, n. 1, p. 48, doi. 10.1002/psp4.12482
- By:
- Publication type:
- Article
Exposure–Response‐Based Product Profile–Driven Clinical Utility Index for Ipatasertib Dose Selection in Prostate Cancer.
- Published in:
- CPT: Pharmacometrics & Systems Pharmacology, 2019, v. 8, n. 4, p. 240, doi. 10.1002/psp4.12394
- By:
- Publication type:
- Article
Development of a Physiologically Based Pharmacokinetic Model for Itraconazole Pharmacokinetics and Drug-Drug Interaction Prediction.
- Published in:
- 2016
- By:
- Publication type:
- journal article
A Phase I Pharmacokinetic Study of Trastuzumab Emtansine (T-DM1) in Patients with Human Epidermal Growth Factor Receptor 2-Positive Metastatic Breast Cancer and Normal or Reduced Hepatic Function.
- Published in:
- 2017
- By:
- Publication type:
- journal article